Upregulation of IGF-2 and IGF-1 receptor expression in oral cancer cell lines

International Journal of Oncology

Volumn 31, Issue 4, 2007, Pages 875-881

  Brady, Garrett ^a   Crean, Stjohn ^b   Naik, Prashant ^c   Kapas, Supriya ^c  

^a LEEDS DENTAL INSTITUTE   (United Kingdom)

^b PRINCE CHARLES HOSPITAL   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

DNA synthesis; Insulin like growth factor receptor; Insulin like growth factors; Oral epithelial cells; Oral squamous cell carcinoma

Indexed keywords

MESSENGER RNA; RNA; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUTH MUCOSA; MOUTH TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MOUTH MUCOSA; MOUTH NEOPLASMS; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 35848956117     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.31.4.875     Document Type: Article

References (46)

1. Wu H, Yu U, Amos CL, Hong WK and Spitz MR: Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. J Natl Cancer Inst 92: 737-743, 2000.
2. Oh Y: IGFBPs and neoplastic models. New concepts for roles of IGFs in regulation of cancer cell growth. J Endocrinol 1: 111-113, 1997.
3. Foulstone E, Prince S, Zaccheo O, Burns JL, Harper J and Jacobs C: Insulin-like growth factor ligands, receptors, and binding proteins in cancer. J Pathol 205: 145-153, 2005. (Pubitemid 40227987)
4. Leroith D and Roberts CT Jr: The insulin-like growth factor system and cancer. Cancer Lett 195: 127-137, 2003. (Pubitemid 36588961)
5. Clemmons DR: Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 8: 45-62, 1997. (Pubitemid 27214688)
6. Ranke MB and Elmlinger M: Functional role of the insulin-like growth factor binding proteins. Horm Res 48S: 9-15, 1997. (Pubitemid 27464727)
7. Baxter RC, Binoux MA, Clemmons DR, et al: Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. Endocrinology 139: 4036, 1998. (Pubitemid 28513685)
8. Hwa V, Oh Y and Rosenfeld RG: The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20: 761-787, 1999. (Pubitemid 30648894)
9. Leroith D: The insulin-like growth factor system. Exp Diab Res 205: 205-212, 2003.
10. O'Connor R: Regulation of IGF-I receptor signaling in tumor cells. Horm Metab Res 35: 771-777, 2003.
11. Larsson O, Girnita A and Girnita L: Role of insulin-like growth factor 1 receptor signalling in cancer. Br J Cancer 92: 2097-2101, 2005.
12. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS and Deroo B: Circulating concentrations of insulin-like growth factor-1 and the risk of breast cancer. Lancet 351: 1993-1996, 1998.
13. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma P and Wilkinson P: Plasma insulin-like growth factor-1 and prostate cancer: a prospective study. Science 279: 563-566, 1998. (Pubitemid 28067285)
14. Hassan AB and Macaulay VM: The insulin-like growth factor system as a therapeutic target in colorectal cancer. Ann Oncol 13: 349-356, 2002.
15. Pollack MN, Scherbhammer ES and Hankinson SE: Insulin-like growth factors and neoplasia. Nat Rev Cancer 4: 505-518, 2004.
16. Ohlsson R: Loss of IGF2 imprinting: mechanisms and consequences. Novartis Found Symp 262: 265-268, 2004.
17. Bhatavdekar JM, Patel DD, Vora HH and Balar DB: Circulating markers and growth factors as prognosticators in men with advanced tongue cancer. Tumour Biol 14: 55-58, 1994.
18. Papadimitrakopoulou VA, Brown EN, Liu DD El-Naggar AK, Jack Lee J, Hong WK and Lee HY: The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis. Cancer Lett 239: 136-143, 2006.
19. Brady G, O'Regan E, Miller I, Ogungbowale A, Kapas S and Crean SJ: Serum levels of insulin like growth factors (IGFs) and their binding proteins (IGFBP's) -1, -2, -3, in oral cancer. Int J Maxillofac Surgery 36: 259-262, 2007.
20. Joseph BK, Savage NW, Daley TJ and Young WG: In situ hybridization evidence for a paracrine/autocrine role for insulin-like growth factor-I in tooth development. Growth Factors 13: 11-17, 1996.
21. Han X and Amar S: IGF-1 signaling enhances cell survival in periodontal ligament fibroblasts vs. gingival fibroblasts. J Dent Res 82: 454-459, 2002.
22. Tsai C-H, Yang S-F, Chen Y-J, Chou M-Y and Chang Y-C: The upregulation of insulin-like growth factor-1 in oral submucous fibrosis. Oral Oncol 41: 940-946, 2005.
23. Neuvians TP, Gashaw I, Hasenfus A, Häcker A, Winterhager E and Grobholz R: Differential expression of IGF components and insulin receptor isoforms in human seminoma versus normal testicular tissue. Neoplasia 7: 446-456, 2005.
24. Coombs NG, Gough AC and Primrose AJ: Optimisation of DNA and RNA from archival formalin-fixed tissue. Nucleic Acids Res 27: E12, 1999.
25. Hagi-Pavli E, Farthing PM, Henshaw FN and Kapas S: Presentation of ICAM-1 protein at the cell surface of oral keratinocytes in the presence of adrenomedullin and corticotrophin. Cell Physiol Biochem 15: 167-174, 2005.
26. Lourenco SV and Kapas S: Integrin expression in developing human salivary glands. Histochem Cell Biol 124: 391-399, 2005.
27. Costigan DC, Guyda HJ and Posner BL: Free insulin-like growth factor-I (IGF-I) and IGF-II in human saliva. J Clin Endocrinol Metab 66: 1014-1018, 1998.
28. Amanso O and Iseki S: Expression, localization and development regulation of insulin-like growth factor I mRNA in rat submandidular gland. Arch Oral Biol 38: 671-677, 1993.
29. Kerr M, Lee A, Wang PL, Purushotham KR, Chegini N and Yamamoto H: Detection of insulin and insulin-like growth factors I and II in saliva and potential synthesis in the salivary glands of mice. Effects of type I diabetes mellitus. Biochem Pharmacol 49: 1521-1531, 1995.
30. Steller MA, Delgado CH, Bartels CJ, Woodworth CD and Zou Z: Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells. Cancer Res 56: 1761-1765, 1996.
31. Steller MA, Delgado CH and Zou Z: Insulin-like growth factor II mediates epidermal growth factor-induced mitogenesis in cervical cancer cells. Proc Natl Acad Sci USA 92: 11970-11974, 1995.
32. Baserga R, Sell C, Porcu P and Rubini M: The role of the IGF-I receptor in the growth and transformation of mammalian cells. Cell Prolif 27: 63-71, 1994.
33. Murphy SK, Huang Z, Wen Y, Spillman MA, Whitaker RS and Simel LR: Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer. Mol Cancer Res 4: 283-292, 2006.
34. Pavelic K, Bukovic D and Pavelic J: The role of insulin-like growth factor 2 and its receptors in human tumors. Mol Med 8: 771-780, 2002.
35. Samani AA, Yakar S, Leroith D and Brodt P: The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28: 20-47, 2007.
36. Quinn KA, Treston AM, Unsworth EJ, Miller MJ, Vos M and Grimley C: Insulin-like growth factor expression in human cancer cell lines. J Biol Chem 271: 11477-11483, 1996.
37. Shaw RJ, Brown JS, Woolgar JA, Lowe D, Rogers SN and Vaughan ED: The influence of the pattern of mandibular invasion on recurrence and survival in oral squamous cell carcinoma. Head Neck 26: 861-869, 2004.
38. Manuel S, Raghavan SK, Pandey M and Sebastian P: Survival in patients under 45 years with squamous cell carcinoma of the oral tongue. Int J Oral Maxillofac Surg 32: 167-173, 2003.
39. Gasparoni A, Fonzi L, Schneider GB, Wertz PW, Johnson GK and Squier CA: Comparison of differentiation markers between normal and two squamous cell carcinoma cell lines in culture. Arch Oral Biol 49: 653-664, 2004.
40. Weber A, Hengge UR, Stricker I, et al: Protein microarrays for the detection of biomarkers in head and neck squamous cell carcinomas. Human Pathol 38: 228-238, 2007.
41. Jerome L, Shiry L and Leyland-Jones B: Deregulation of the IGF axis in cancer: epidemiologival evidence and potential therapeutic interventions. Endo-Related Cancer 10: 561-578, 2003.
42. Yee D: Targeting insulin-like growth factor pathways. Br J Cancer 94: 465-468, 2006.
43. Miller BS and Yee D: Type I insulin-like growth factor receptor as a therapeutic target in cancer. Cancer Res 65: 10123-10127, 2005.
44. Hofmann F and Garcia-Echeverria C: Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer. Drug Discov Today 10: 1041-1047, 2005.
45. Butler AA, Blakesley VA, Poulaki V, et al: Stimulation of tumor growth by recombinant human insulin-like growth factor-I (IGF-I) is dependent on the dose and the level of IGF-I receptor expression. Cancer Res 58: 3021-3027, 1998.
46. Baserga R: The IGF-I receptor in cancer research. Exp Cell Res 253: 1-6, 1999.